These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4640695)

  • 1. Hepatic encephalopathy evaluated by automatic period analysis of the electroencephalogram during lactulose treatment.
    Kardel T; Olsen PZ; Stigsby B; Tonnesen K
    Acta Med Scand; 1972 Dec; 192(6):493-8. PubMed ID: 4640695
    [No Abstract]   [Full Text] [Related]  

  • 2. Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study.
    Rorsman G; Sulg I
    Acta Med Scand; 1970 May; 187(5):337-46. PubMed ID: 5526951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 4. [A corrector of the metabolism of colonic bacteria: modern treatment of portacaval encephalopathies].
    Lande M; Clot C
    Sem Ther; 1968 Dec; 44(10):672-4. PubMed ID: 5706296
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
    Morgan MY; Alonso M; Stanger LC
    J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lactulose in the therapy of porto-systemic encephalopathy].
    Almici C; Inzoli MR; Poloni AE; Zambruni A
    Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 12. Encephalopathy after portacaval shunting managed with lactulose.
    Brown H; Trey C; McDermott WV
    Am J Surg; 1970 Feb; 119(2):132-7. PubMed ID: 5440784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lactulose in the treatment of chronic portosystemic encephalopathies].
    Seidlová V
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
    Fischer JE
    Arch Surg; 1974 Mar; 108(3):325-36. PubMed ID: 4149791
    [No Abstract]   [Full Text] [Related]  

  • 15. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
    Morgan MY; Hawley KE
    Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic encephalopathy. Physiopathology and treatment].
    Perney P; Pomier-Layrargues G
    Gastroenterol Clin Biol; 1994; 18(12):1069-76. PubMed ID: 7750679
    [No Abstract]   [Full Text] [Related]  

  • 17. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
    Loguercio C; Del Vecchio Blanco C; Coltorti M
    J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic hepatic encephalopathy with lactulose.
    Fung WP; Khoo OT
    Med J Aust; 1968 Jul; 2(4):160-3. PubMed ID: 5670884
    [No Abstract]   [Full Text] [Related]  

  • 20. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
    Lanthier PL; Morgan MY
    Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.